Japanese Retail REITs Stock News

TSE:4536
TSE:4536Pharmaceuticals

MHRA Approval of Ryjunea® Could Be a Game Changer for Santen Pharmaceutical (TSE:4536)

In the past week, Santen Pharmaceutical announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) approved Ryjunea® (low-dose atropine 0.1 mg/ml) as the first licensed treatment to slow the progression of myopia in children, following earlier European Commission approval and launches in Europe. This milestone offers Santen a new opportunity to address the rising prevalence of childhood myopia in the UK and further strengthens its international presence in paediatric...
TSE:3563
TSE:3563Hospitality

Will Food & Life (TSE:3563) Earnings Insights Shape Investor Confidence in Its Long-Term Strategy?

Food & Life Companies recently held its 2025 earnings call on November 7, 2025, providing investors with updates on its financial and operational performance. This regular event serves as a key opportunity for stakeholders to assess the company's progress and reassess expectations going forward. With the earnings call drawing attention, we'll explore how updated financial insights may influence Food & Life Companies’ investment narrative. We've found 16 US stocks that are forecast to pay a...
TSE:4202
TSE:4202Chemicals

Will Daicel’s (TSE:4202) Buyback Plan Mark a Shift in Its Capital Efficiency Strategy?

On November 6, 2025, Daicel Corporation's Board of Directors announced a share repurchase program, authorizing the buyback of up to 11,000,000 shares, equivalent to 4.14% of its issued share capital, for a maximum total of ¥15,000 million by March 31, 2026. This move is part of Daicel's medium-term capital policy, aiming to enhance shareholder returns and promote more efficient use of capital. We'll explore how Daicel's substantial buyback initiative shapes the company's investment narrative...
TSE:7741
TSE:7741Medical Equipment

How HOYA’s (TSE:7741) Record Interim Dividend Signals a Shift in Its Investment Narrative

On October 31, 2025, HOYA Corporation's board approved an interim dividend of ¥125.00 per share for shareholders of record as of September 30, 2025, a very large increase compared to the ¥45.00 per share paid the previous year, with payment scheduled for November 28, 2025. This substantial dividend increase highlights HOYA's capacity to return more capital to shareholders and signals management's confidence in its financial position. We now explore how this unusually large interim dividend,...